RSF seeks press freedom pledges from Maldives presidential candidates Reporters Without Borders is very concerned about Ahmed Rilwan Abdulla, a reporter who disappeared ten days ago, and urges the Maldives authorities to deploy whatever resources are necessary to find him. Rilwan, 28, has worked for the independent online newspaper Minivan News since December 2013, mainly covering religious issues, politics and the environment. He is also a former member of the Human Rights Commission of Maldives.On 4 August, four days before he went missing, he wrote a story about a threatening SMS received by 15 journalists who cover organized crime. Minivan News says all the evidence points to his having been abducted.“We are extremely worried by Rilwan’s disappearance and urge the authorities to step up their efforts to find him as quickly as possible,” said Reporters Without Borders secretary-general Christophe Deloire. “There is every reason to be concerned about Rilwan, especially as gangs and religious extremists are very often responsible for threats to journalists. Ismail Hilath Rasheed, a freelance journalist known for his support for religious tolerance, only narrowly survived a murder attempt in June 2012.”Surveillance camera footage at a Malé ferry terminal shows Rilwan buying a ticket at around 12:45 a.m. on 8 August and going to the waiting area to take the ferry to the Malé suburb of Hulhumalé. According to Minivan News, witnesses saw a man meeting his description being kidnapped near his Hulhumalé apartment shortly thereafter. He has not been seen since then.A website and a hotline have been created to help efforts to locate Rilwan. Anyone with information about his disappearance or whereabouts should call the police hotline, +960 332 2111, or the Serious and Organized Crime Department at +960 991 1099.Maldives is ranked 108th out of 180 countries in the 2014 Reporters Without Borders press freedom index.Photo: Minivan News News Follow the news on Maldives September 12, 2018 Find out more RSF calls for open trial of Maldivian blogger’s accused murderers News RSF_en Receive email alerts MaldivesAsia – Pacific Maldivian president’s comms chief accused of sexually harassing journalist to go further News Help by sharing this information April 23, 2018 Find out more Organisation News MaldivesAsia – Pacific All the evidence indicates that Minivan News reporter Ahmed Rilwan was abducted in the early hours of 8 August August 18, 2014 – Updated on January 20, 2016 Reporter missing for past 10 days in Maldives July 15, 2020 Find out more
FMBA 11 defeated BYPA, 11 – 5. For FMBA, Caitlyn Gaetani scored 6, Kayla SantoPietro with 2, Katherine Sorrentino with 2 and Sheila O’Neill with 1. For BYPA, Cyniah Smith scored 3 and Shea Torres with 2.Mayor Jimmy Davis beat Assemblyman Nicholas Chiaravalloti, 14 – 13. For Mayor Jimmy Davis, Samantha Russell scored 10, Tamaya Thomas with 2 and Kylie Hall with 2. For Assemblyman Nicholas Chiaravalloti, Riley Williams scored 5, Kennedi Cotter with 4 and Giselle Davis with 2.
Editor’s note: This story was updated Aug 7 to include information about the start of influenza vaccine shipments by Novartis.Aug 6, 2008 (CIDRAP News) – The six companies that make influenza vaccine for the US market have won federal approval for their version of this year’s vaccine, in which all three flu strains used in last year’s product have been replaced, the Food and Drug Administration (FDA) announced yesterday.The FDA announcement clears the way for marketing of the vaccines. At least three vaccine makers have begun shipping vaccine to distributors and providers, according to recent company announcements.The six manufacturers and their vaccines are CSL Limited, Afluria; GlaoxSmithKline Biologicals, Fluarix; ID Biomedical Corp. of Quebec (a unit of GlaxoSmithKline), FluLaval; MedImmune, FluMist; Novartis Vaccines and Diagnostics, Fluvirin; and Sanofi Pasteur, Fluzone.In the wake of a relatively poor match between the vaccine and circulating flu strains last season, experts at the World Health Organization and the FDA in February recommended changing all three strains of virus used in the vaccine. In most years only one or two of the three strains are changed.”One of the biggest challenges in the fight against influenza is producing new vaccines every year,” Jesse Goodman, MD, MPH, director of the FDA’s Center for Biologics Evaluation and Research, said in a news release. “There is no other instance where new vaccines must be made every year.”Two of the three strains in the 2008-09 vaccine are included in vaccines now being used in the Southern Hemisphere, where the flu season is under way, the FDA noted.The decision to change all three strains in the vaccine had generated some concern about possible production delays or low yields of the viruses, which are grown in eggs. But Curtis Allen, a spokesman for the National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention (CDC) in Atlanta, said today he hasn’t heard of any problems growing the strains.”Vaccine production is always fraught with risk and anywhere along the line things can go wrong, but so far they have not, and we’re looking forward to a season with adequate supplies of vaccine,” Allen told CIDRAP News.At a meeting in May, manufacturers estimated they would produce a record total of 143 million to 146 million doses of flu vaccine for the US market this year. Allen said the estimates of vaccine production have not changed since then. Last year 140 million doses were produced.Allen listed the manufacturers’ production estimates as follows: Sanofi Pasteur, 50 million doses; GlaxoSmithKline (including ID Biomedical), 35 million to 38 million; MedImmune, 12 million; Novartis, 40 million; and CSL, 6 million.Sanofi announced Aug 1 that it had begun shipping the first 1.3 million doses of Fluzone. “Vaccine shipments to healthcare providers and to the [CDC] for distribution through the Vaccines for Children Program will continue through the fall and are planned to be completed in October,” the company said in a news release.The statement indicated that replacing all three strains of virus has not caused any major production problems.”Introduction of three new strains for the influenza vaccine was unprecedented and could have resulted in a low yield or delay given our tight production timeline. Despite these challenges, we are pleased that once again Sanofi Pasteur has demonstrated its reliability in supplying Fluzone vaccine to the US market,” said Wayne Pisano, the company’s president and chief executive officer, in the news release.MedImmune announced yesterday that shipments of FluMist, a nasal-spray vaccine that uses a weakened form of live virus, had begun on Jul 31. In a news release, the company affirmed that it plans to produce about 12 million doses, a record number.FluMist will be available at some retail pharmacies and supermarkets and in nearly 200 school-based vaccination programs and university health centers, the company said. In addition, the federal government, as in past years, is buying some doses for use in military personnel, officials said.Novartis announced Aug 7 that it has begun shipping Fluvirin to US healthcare providers. The company said it expects to deliver 20 million doses by the end of September and aims to deliver the remaining 20 million by Oct 31. Officials said the company has added a second manufacturing facility, located in Rosia, Italy, to help supply flu vaccine earlier in the season. The firm’s other facility is in Liverpool, England.”Despite the new composition [of the vaccine], Novartis made sure we were able to deliver a timely and robust supply of influenza vaccine this year,” said Rajiv De Silva, president of Novartis Vaccines in the US, in a news release.This is the first year the CDC is formally recommending flu shots for school-age children, adding about 30 million people to the ranks of those targeted for vaccination. Allen said the total number of those targeted for vaccination—including people at risk for serious flu complications and their close contacts—is about 258 million, or roughly 84% of the population.See also: Aug 5 FDA news releasehttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116933.htmFDA page with chart of vaccine lot releaseshttp://www.fda.gov/cber/flu/flu2008.htmAug 4 MedImmune news releaseAug 1 Sanofi Pasteur news releasehttp://www.vaccineplace.com/docs/first_shipment_release.pdfMay 13 CIDRAP News story “Flu experts try to ensure record vaccine doses get used”Feb 22 CIDRAP News story “FDA endorses overhaul for 2008-09 flu vaccine”
Written By WATCH US LIVE SUBSCRIBE TO US First Published: 6th August, 2020 09:53 IST COMMENT LIVE TV Yu Darvish pitched seven sharp innings and the Chicago Cubs beat the skidding Kansas City Royals 6-1 on Wednesday night for their sixth straight victory.Javier Báez drove in two runs for the Cubs (10-2), who handed Kansas City its sixth consecutive defeat. Kris Bryant and Anthony Rizzo each had two hits and scored twice.Darvish (2-1) was in midseason form for the second straight outing. He gave up five hits, struck out four and walked one.With the score 2-1, the Royals’ best chance to tie the game came in the sixth when Whit Merrifield was on third with one out. Darvish struck out Ryan O’Hearn and retired Salvador Perez on a grounder, ending the threat.The Cubs capitalized on one bad stretch for Royals starter Kris Bubic, who set down his first nine batters, including four strikeouts, before Bryant singled in the fourth.Rizzo followed with a walk, and then a bloop hit by Báez tied it 1-all. Willson Contreras grounded into a double play, but Rizzo scored to give the Cubs a 2-1 lead.Kansas City (3-10) started the scoring in the third when a double off the left-field wall by Maikel Franco was followed by Nicky Lopez’s single, but a potential big inning was thwarted when Merrifield grounded into a double play.The Cubs took advantage of two fielding mistakes in the eighth and ninth, tacking on four runs to make it 6-1.Bubic (0-2), making his second career start, went six innings and gave up two runs. He struck out six.TRAINER’S ROOMRoyals: Before the game, OF Bubba Starling and RHP Glenn Sparkman were placed on the injured list. Starling was batting .211 with three RBIs. Sparkman had a 5.40 ERA and allowed nine hits in four appearances. Kansas City recalled catcher Meibrys Viloria and RHP Scott Blewett.UP NEXTRoyals RHP Brad Keller makes his season debut Thursday night after returning from the IL due to COVID-19. RHP Tyler Chatwood (2-0, 0.74 ERA) will start for the Cubs. “I feel pretty good,” Keller said Saturday. “Whenever they tell me, I’ll be ready.”Image credits: AP FOLLOW US Associated Press Television News Last Updated: 6th August, 2020 09:53 IST Darvish Pitches Cubs Past Royals 6-1 For 6th Straight Win Yu Darvish pitched seven sharp innings and the Chicago Cubs beat the skidding Kansas City Royals 6-1 on Wednesday night for their sixth straight victory